Renate S. Hagedoorn

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes.

T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes.

Journal: Journal for immunotherapy of cancer

Published: August 02, 2026

Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ-Specific B Cells.

Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ-Specific B Cells.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 13, 2026

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Journal: Journal of ovarian research

Published: February 23, 2026

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Journal: Journal of ovarian research

Published: February 23, 2026

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Journal: Blood

Published: December 09, 2025

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

Journal: Leukemia

Published: June 14, 2025

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Journal: Cancer immunology research

Published: January 14, 2025

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

Journal: Molecular therapy. Oncology

Published: August 28, 2024

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 08, 2024

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Journal: Molecular therapy oncolytics

Published: November 03, 2023

Mtb HLA-E-tetramer-sorted CD8+ T cells have a diverse TCR repertoire.

Mtb HLA-E-tetramer-sorted CD8+ T cells have a diverse TCR repertoire.

Journal: iScience

Published: October 18, 2023

Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells.

Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells.

Journal: Cancer gene therapy

Published: July 25, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026